TERF2

Telomeric repeat-binding factor 2 · Q15554 · TERF2 on Sugi Atlas →

1,202 patent compounds predicted against TERF2, 495 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL29779770 SCHEMBL29779770 0.53 9/20
SCHEMBL12856031 SCHEMBL12856031 0.39 8/20
SCHEMBL22105950 SCHEMBL22105950 0.38 7/20
SCHEMBL22677610 SCHEMBL22677610 0.38 7/20
SCHEMBL17888971 SCHEMBL17888971 0.34 7/20
SCHEMBL17992357 SCHEMBL17992357 0.39 6/20
SCHEMBL21335115 SCHEMBL21335115 0.39 6/20
SCHEMBL30818425 SCHEMBL30818425 0.34 6/20
SCHEMBL30818426 SCHEMBL30818426 0.34 6/20
SCHEMBL19532409 SCHEMBL19532409 0.49 5/20
SCHEMBL14952656 SCHEMBL14952656 0.48 5/20
SCHEMBL17413318 SCHEMBL17413318 0.46 5/20
SCHEMBL14971405 SCHEMBL14971405 0.44 5/20
SCHEMBL21335300 SCHEMBL21335300 0.44 5/20
SCHEMBL22106077 SCHEMBL22106077 0.44 5/20
SCHEMBL17992333 SCHEMBL17992333 0.43 5/20
SCHEMBL22105904 SCHEMBL22105904 0.43 5/20
SCHEMBL22678340 SCHEMBL22678340 0.42 5/20
SCHEMBL22429493 SCHEMBL22429493 0.39 5/20
SCHEMBL22429645 SCHEMBL22429645 0.39 5/20

Clinical trials — most relevant to TERF2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Nandrolone Decanoate in the Treatment of Telomeropathies PHASE1/PHASE2COMPLETED
Low-Dose Danazol for the Treatment of Telomere Related Diseases PHASE2COMPLETED
Danazol for Genetic Bone Marrow and Lung Disorders PHASE1/PHASE2COMPLETED
Danazol for Treatment of Cytopenias in Patients With Cirrhosis PHASE2RECRUITING
Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma PHASE1WITHDRAWN
Nucleoside Therapy in Patients With Telomere Biology Disorders PHASE1RECRUITING
Telomeres Length in Israeli Fibrotic ILD Patients nanENROLLING_BY_INVITATION
Biological Aging Hallmarks-Guided Integrative TCM and Conventional Medicine in Post-Treatment Unexplained Female Infertility nanRECRUITING
Telomere Disclosure and Impact on Psychological Distress and Health Behaviors nanCOMPLETED
Telomere and Telomerase nanWITHDRAWN
Body Awareness and Aerobic Exercise: Telomere Impact nanCOMPLETED
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants nanRECRUITING
Telomere Repair Gene Mutation in Inflammatory Bowel Disease nanCOMPLETED
Telomeric Abnormalities in Colorectal Diseases by Fluorescent in Situ Hybridization Technique nanUNKNOWN
Anti-age Dietary Supplements in Healthy Older Adults: the proBNPage Reduction Trial nanUNKNOWN
Telomerase Activator and Retinal Amyloid nanCOMPLETED
Aerobic Exercise and Telomere Length in Patients With Heart Failure. nanUNKNOWN
Mitochondrial DNA Copy Number and Leukocyte Telomere Length as Biomarkers in Type 2 Diabetic Patients nanUNKNOWN
Nasal Brushing for the Diagnosis and Understanding of Telomeropathies nanUNKNOWN
Cyclin-dependent Kinase Inhibitor 2A (Placental Senescence Marker) on Labor-related Signals nanUNKNOWN
Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma nanUNKNOWN
Chromosomal Translocations in Chandigarh Police nanCOMPLETED
Self-Directed Biological Transformation Initiative nanCOMPLETED
Vascular Senescence and Atherosclerotic Plaque Vulnerability nanRECRUITING
Natural History of Acquired and Inherited Bone Marrow Failure Syndromes nanRECRUITING
Impact of Bariatric and Metabolic Surgery on the Reduction of Premature Aging. nanCOMPLETED
Impact of Diet and Physical Activity Changes on Body Weight, Biomarkers and Quality of Life in Breast Cancer Survivors nanCOMPLETED
Influence of Prostate Cancer Radiation on Aging nanCOMPLETED
Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research Study nanENROLLING_BY_INVITATION
Genetic Biomarkers of Executive Stress nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a TERF2 binder may also engage these)

ProteinNameSimilarity
O35144 1.000 O35144 →
Q9QXM1 0.991 Q9QXM1 →
Q32LQ1 0.991 Q32LQ1 →
Q8K3I4 0.991 Q8K3I4 →
Q8TF30 0.988 Q8TF30 →
Q62925 0.988 Q62925 →
Q6P1H6 0.988 Q6P1H6 →
Q5PQX1 0.987 Q5PQX1 →
Q62315 0.987 Q62315 →
Q9PU53 0.987 Q9PU53 →
Q9Y5B0 0.987 Q9Y5B0 →
Q96RY5 0.987 Q96RY5 →
Q58CQ0 0.987 Q58CQ0 →
Q9ULM0 0.986 Q9ULM0 →
Q5HYC2 0.986 Q5HYC2 →
Q921T2 0.986 Q921T2 →
Q8K136 0.986 Q8K136 →
Q7L190 0.986 Q7L190 →
Q6ZW76 0.986 Q6ZW76 →
SNAPC4 snRNA-activating protein complex subunit 4 0.986 landscape →
Q92833 0.986 Q92833 →
Q92543 0.986 Q92543 →
E1U8D0 0.986 E1U8D0 →
A2A9T0 0.986 A2A9T0 →
A6ND36 0.985 A6ND36 →
Q6P9J5 0.985 Q6P9J5 →
Q501R9 0.985 Q501R9 →
Q8N5H7 0.985 Q8N5H7 →
Q5JTD0 0.985 Q5JTD0 →
Q9Y6A5 0.985 Q9Y6A5 →